What the company does
GH Research PLC is a clinical-stage biopharmaceutical company at the forefront of developing psilocybin-based therapies for psychiatric and neurodegenerative disorders. The company boasts a robust pipeline aimed at addressing critical unmet needs in mental health care, driven by a highly experienced team committed to innovation in this rapidly evolving field. By pioneering groundbreaking therapeutic approaches, GH Research is well-positioned to redefine treatment paradigms and enhance patient outcomes, establishing itself as a potential leader in the mental health therapeutics market.
What the weekly tape is saying
GHRS closed the latest completed week at 21.12 USD. The 4-week return is -1.3% and the 12-week return is 51.2%. Trend Signal is active, Market Dynamics is 1.27. Setup signature: Balanced read with a 70/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 16.66 USD
- Vs Trend Line
- 26.8%
- Fair Value
- 11.68 USD
- Vs Fair Value
- 80.8%
- 52W High
- 25.94 USD
- 52W Low
- 11.32 USD
- Drawdown
- -18.6%
- Range Position
- 67.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 10 weeks
- 52W Active Weeks
- 47
- 52W Active Breadth
- 90.4%
- Sector Scope
- US Healthcare
- Sector Rank
- 663 of 1038
- Sector Percentile
- 36.2%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.27
- 4W MD Change
- -15.8%
- Relative Strength
- 16.72
- 4W RS Change
- -27.6%
- Expectation
- Undecided
- Probability
- 51.31%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.2M
- 13W Average
- 1.1M
- 52W Average
- 1.4M
- Vs 13W
- 1.1x
- Vs 52W
- 0.8x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 7.6%
- 52W Volatility
- 8.0%
- Upside Weeks
- 29
- Downside Weeks
- 23
- Downside Breadth
- 44.2%
- Avg Gain / Loss
- 7.1% / -6.0%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 1.5B
Opportunity signals
- Trend Signal is active with a 10-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
Risk signals
- No major top-level risk cluster is currently dominant.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 21.12 USD | -1.4% | 16.66 USD | 11.68 USD | 1.27 | 16.72 | 1.2M | On |
| 5 Jun 2026 | 21.43 USD | -10.7% | 16.42 USD | 11.62 USD | 1.45 | 21.63 | 1.4M | On |
| 29 May 2026 | 23.99 USD | 8.5% | 16.15 USD | 11.56 USD | 1.56 | 30.70 | 1.0M | On |
| 22 May 2026 | 22.12 USD | 3.4% | 15.83 USD | 11.48 USD | 1.56 | 24.89 | 1.7M | On |
| 15 May 2026 | 21.39 USD | -0.1% | 15.56 USD | 11.41 USD | 1.51 | 23.07 | 685.7K | On |
| 8 May 2026 | 21.42 USD | 3.4% | 15.30 USD | 11.34 USD | 1.27 | 23.72 | 1.1M | On |
| 1 May 2026 | 20.71 USD | 2.3% | 15.00 USD | 11.27 USD | 0.82 | 27.08 | 900.6K | On |
| 24 Apr 2026 | 20.25 USD | 10.4% | 14.75 USD | 11.20 USD | 0.31 | 26.92 | 3.0M | On |
| 17 Apr 2026 | 18.34 USD | 16.7% | 14.55 USD | 11.12 USD | -0.30 | 18.58 | 719.6K | On |
| 10 Apr 2026 | 15.72 USD | 7.9% | 14.39 USD | 11.06 USD | -0.53 | 8.60 | 453.6K | On |
| 2 Apr 2026 | 14.57 USD | 10.8% | 14.26 USD | 11.01 USD | -0.49 | 5.64 | 524.5K | Off |
| 27 Mar 2026 | 13.15 USD | -5.9% | 14.24 USD | 10.97 USD | -0.29 | -0.78 | 783.3K | Off |
| 20 Mar 2026 | 13.97 USD | -6.6% | 14.26 USD | 10.94 USD | -0.07 | 1.97 | 1.1M | On |
| 13 Mar 2026 | 14.95 USD | -6.2% | 14.23 USD | 10.90 USD | 0.12 | 6.80 | 1.5M | On |